Showing results (1-10 of 110) with videos related to
Sort By:
Pageof 11
Current Bladder Dysfunction Reports|May 13, 2014
Two-micron (Thulium) Laser Prostatectomy: An Effective Method for BPH TreatmentQi Jiang, Shujie XiaFrontiers in Nutrition|February 11, 2025
Association between the dietary inflammatory index and depressive symptoms in adults with metabolic syndrome: a cross-sectional study from the NHANES databaseJinshun You, Shujie XiaZhonghua Yi Xue Za Zhi|February 17, 2016
[Cost and effectiveness analysis of treatments for benign prostatic hyperplasia]Chen Zhong, Wei Wen, Shujie XiaAsian Journal of Urology|December 22, 2017
Thulium laser treatment for bladder cancerWei Wang, Haitao Liu, Shujie XiaZhonghua Nan Ke Xue = National Journal of Andrology|December 15, 2004
[Expression and clinical significance of antiapoptosis gene XIAP in prostate cancer]Jianhe Liu, Ming Li, Shujie XiaWorld Journal of Urology|March 23, 2010
Clinical observation on 2 micron laser for non-muscle-invasive bladder tumor treatment: single-center experienceChen Zhong, Sanwei Guo, Yueqing Tang, et al.Current Urology|May 2, 2025
Beyond size: A comprehensive overview of small-volume benign prostatic hyperplasiaJunhao Xu, Bangmin Han, Shujie Xia, et al.Current Urology|August 6, 2025
Emphasis on the management of embedded capsular hyperplasia nodules associated with benign prostatic hyperplasiaChenghao Zheng, Yiping Zhu, Yifeng Jing, et al.World Journal of Urology|March 12, 2014
Estrogen receptor β (ERβ) is a novel prognostic marker of recurrence survival in non-muscle-invasive bladder cancer potentially by inhibiting cadherin switchBangmin Han, Di Cui, Yifeng Jing, et al.World Journal of Urology|January 13, 2012
Estrogen receptor β (ERβ) is a novel prognostic marker of recurrence survival in non-muscle-invasive bladder cancer potentially by inhibiting cadherin switchBangmin Han, Di Cui, Yifeng Jing, et al.Pageof 11